Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London flag London · Delayed Price · Currency is GBP · Price in USD
546.04
-2.27 (-0.41%)
At close: Aug 1, 2025

United States Steel Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of 43.75 billion as of August 1, 2025. Its market cap has decreased by -52.02% in one year.

Market Cap
43.75B
Enterprise Value
32.56B
Revenue
10.37B
Ranking
n/a
PE Ratio
13.44
Stock Price
$546.04

Market Cap Chart

Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 43.75B, an increase of 45,413.55%. That is a compound annual growth rate of 20.34%.

History

DateMarket Cap% Change
Jul 31, 202543.59B-28.80%
Dec 31, 202461.22B-16.52%
Dec 29, 202373.33B14.66%
Dec 30, 202263.95B31.15%
Dec 31, 202148.76B30.57%
Dec 31, 202037.35B20.50%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition